These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4133358)

  • 1. [Prophylaxis and treatment of erysipelous inflammation].
    Tserentsian DM
    Klin Khir (1962); 1974 Mar; 3():73-4. PubMed ID: 4133358
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of specific gamma-globulin in the treatment of erysipelas and the prevention of relapse].
    Khlestkov AA
    Klin Med (Mosk); 1973 Feb; 51(2):113-7. PubMed ID: 4121734
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative evaluation of the results of the treatment of erysipelas].
    Brisker AD; Ebert LIa; Khlestkov AA
    Sov Med; 1973 Dec; 36(12):122-3. PubMed ID: 4130664
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of specific gamma-globulin and pentoxyl on the immunological reactivity of the body in erysipelas].
    Ebert LIa; Khovanova AM; Brisker AD; Khlestkov AA
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Sep; 49(9):52-7. PubMed ID: 4120013
    [No Abstract]   [Full Text] [Related]  

  • 5. [Possibility of increasing the efficacy of antibiotic therapy of erysipelas using combinations of methyluracil with prodigiozan].
    Frolov VM; Rychnev VE
    Antibiot Med Biotekhnol; 1985 May; 30(5):375-8. PubMed ID: 4026258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinico-immunological evaluation of antibiotic thereapy and prevention of frequent recurrences of erysipelas].
    Cherkasov VL; Iakhontova NK; Chistenkov NA
    Klin Med (Mosk); 1974 Feb; 52(2):52-7. PubMed ID: 4466916
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immune preparations in the overall therapy and prevention of erysipelatous inflammation].
    Khlestkov AA; Raskovalov MG; Ebert LIa
    Voen Med Zh; 1976 Jan; (1):48-9. PubMed ID: 1258419
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrent erysipelas despite antibiotic prophylaxis: an analysis from case studies.
    Koster JB; Kullberg BJ; van der Meer JW
    Neth J Med; 2007 Mar; 65(3):89-94. PubMed ID: 17387234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Principles of treatment of patients with recurrent erysipelas].
    Cherkasov VL; Samotolkin KN
    Vrach Delo; 1983 Feb; (2):113-6. PubMed ID: 6845687
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunomodulating therapy of middle-aged and elderly patients with erysipelas].
    Frolov VM; Rychnev VE; Razenkova AT; Baskakov IN; Gurina AA
    Vrach Delo; 1987 Jul; (7):103-5. PubMed ID: 3630100
    [No Abstract]   [Full Text] [Related]  

  • 11. [Erysipelas].
    van der Waal RI
    Ned Tijdschr Tandheelkd; 2011 Jun; 118(6):308. PubMed ID: 21766527
    [No Abstract]   [Full Text] [Related]  

  • 12. [Erysipelas. Retrospective study of 647 patients].
    Zaraa I; Zeglaoui F; Zouari B; Ezzine N; Fazaa B; Kamoun MR
    Tunis Med; 2004 Nov; 82(11):990-5. PubMed ID: 15822466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biomycin electrophoresis in the treatment of erysipelous inflammation of the extremities].
    Mirashkin VV
    Sov Med; 1976 Oct; (10):147-8. PubMed ID: 1023373
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrent erysipelas: 47 cases.
    Leclerc S; Teixeira A; Mahé E; Descamps V; Crickx B; Chosidow O
    Dermatology; 2007; 214(1):52-7. PubMed ID: 17191048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recurrent erysipelas and bilateral congenital lymphedema].
    Ruiz Villaverde R; Martínez Larios B; Páramo Rodríguez E; Blasco Melguizo J; Martín Sánchez MC
    Rev Clin Esp; 2003 Aug; 203(8):403-5. PubMed ID: 12855125
    [No Abstract]   [Full Text] [Related]  

  • 16. Penicillin as a therapeutic option in the treatment of in-hospital erysipelas.
    Pereira De Godoy JM; Ribeiro A; Cozzetto De Oliveira AL; Batigalia F
    G Ital Dermatol Venereol; 2014 Feb; 149(1):150-1. PubMed ID: 24566577
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of erysipela: an update].
    Chosidow O
    Med Mal Infect; 2005 Jun; 35 Suppl 2():S61-2. PubMed ID: 15978391
    [No Abstract]   [Full Text] [Related]  

  • 18. [The erysipelas as complication of a lymph oedema after therapy of mastocarcinomas (author's transl)].
    Keinert K; Schalldach U; Schumann E
    Strahlentherapie; 1981 Feb; 157(2):91-3. PubMed ID: 7222137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A sudden redness and swelling of the face].
    Vos MD; Bos RR; Vissink A
    Ned Tijdschr Tandheelkd; 2009 Jul; 116(7):383-6. PubMed ID: 19673238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellulitis and erysipelas.
    Morris A
    Clin Evid; 2002 Jun; (7):1483-7. PubMed ID: 12230764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.